Clinical Trial Imaging Industry: Growth Drivers and Trends
According to FutureWise analysis, the market for Clinical Trial Imaging in 2023 is US$1.3 billion, and is expected to reach US$2.36 billion by 2031 at a CAGR of 7.70%.
In 2024, the global clinical trial imaging market was valued at approximately USD 1.23 billion and is poised for significant growth, projected to reach around USD 1.91–2.07 billion by the end of the decade. This growth reflects a compound annual growth rate (CAGR) of about 7.8–7.9% from 2025 to 2030. Several key factors are driving this expansion, including increased research and development expenditure in the pharmaceutical and biotech industries, a greater adoption of advanced imaging technologies—particularly CT and MRI—and a strong demand from contract research organizations (CROs). Regionally, North America leads the market, holding the largest share, while the Asia-Pacific region, especially China, is emerging as a rapidly growing player. This growth can be attributed to cost advantages and an uptick in clinical trial activities in the region.
FutureWise Market Research has released a report that provides an in-depth analysis of Clinical Trial Imaging Market trends that will impact the overall market growth. Furthermore, it includes detailed information on the profitability graph, SWOT analysis, market share, and regional expansion of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market
Request a Free Sample @
https://www.futurewiseresearch.com/contact.aspx?rpt=9849&type=requestsample
Clinical Trial Imaging Market Segmentation:
By Product and Service
- Services
- By Therapeutic area
- Read Analysis Services
- System and Technical Support Services
- Trial Design and Consulting Services
- Software
By Modality
- Computed Tomography
- Magnetic Resonance Imaging
- Ultrasound
- Positron Emission Tomography
- X-ray
- Echocardiography
By Therapeutic Area
- Oncology
- Infectious Diseases
- Neurology
- CVS
- Endocrinology
- Immunological Disorder
By End User
- Pharmaceutical Companies
- Biotechnology Companies
- Medical Device Manufacturer
- Contract Research Organizations
- Academic and Government Research Institutes
By Region
- North America
- Europe
- Asia-Pacific
- Latin America
- Middle East and Africa
Competitive Landscape in Clinical Trial Imaging Market:
- ICON plc.
- BioTelemetry Inc.
- Biomedical Systems Corporation
- Medpace Holdings, Inc.
- IXICO plc.
- Resonance Health Ltd.
- Radiant Sage LLC
- BioClinica Inc.
- Intrinsic Imaging LLC
- Cardiovascular Imaging Technologies LLC
- Medical Metrics Inc.
- Prism Clinical Imaging, Inc.
- Boston Imaging Core Lab LLC
- Anagram 4 Clinical Trials
- Lyscaut Medical Imaging Company
- Calyx Group
- Bioseptive Inc.
- ProScan Imaging LLC
- Micron Inc.
- Imaging Endpoints LI, LLC
Buy now the latest version of this report: https://www.futurewiseresearch.com/checkout.aspx?ReportId=9849&license=multi
**Objectives of this Study: **
- To provide a comprehensive analysis of the Clinical Trial Imaging Market By Product and Service, By Modality, By End User, and By Region.
- To offer detailed insights into factors such as drivers, restraints, trends, and opportunities, as well as segmental and regional influences on market growth.
- To evaluate current market trends and forecast micro-markets, presenting overall market projections in the form of data sets and PowerPoint presentations.
- To predict the market size in key regions, including North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa.
Flexible Delivery Model:
- We have a flexible delivery model and you can suggest changes in the scope/table of contents as per your requirement
- The customization services offered are complimentary with the purchase of any report license.
- You can directly share your requirements/changes to the current table of contents to: [email protected]
